Check out the top stories from last month www.statnews.com/stat-plus Check out last month's top stories. If you like what you see, join the STAT+ community today — and enjoy 25% off your first year. MIKE REDDY FOR STAT BIOTECH VC deals and valuations begin falling apart amid biotech’s stock shock by Allison DeAngelis CASEY SHENERY FOR STAT STAT INVESTIGATION Internal documents show privacy lapses at a data powerhouse that holds health records and consumer information on millions of Americans by Casey Ross More stories: Four brain-computer interface companies you should watch (other than Neuralink) by Elissa Welle Researchers tried to calculate the impact of health tech companies. It sent startups into a tizzy by Mohana Ravindranath UnitedHealth Group says Medicare Advantage saves money, but the data say otherwise by Bob Herman Health tech funding is down. Here’s what investors make of the market by Mario Aguilar Not-so-happy midyear! Biotech CEOs, best and worst, and a hopeful sign of a turnaround by Adam Feuerstein ‘No magic bullet’: For drugmakers and the FDA, clinical trials on ultra-rare diseases pose thorny challenges by Ed Silverman Here’s what Democrats changed in their latest drug pricing bill by Rachel Cohrs In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans by Lev Facher Subscribe now to enjoy 25% off your first year. SUBSCRIBE Wednesday, August 3, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments